70 results on '"rolipram"'
Search Results
2. Radiocomplexation, Quality Control and Bioevaluation of [99mTc]tricarbonyl Rolipram for Brain Imaging in Mice
3. Targeting Aquaporin-5 by Phosphodiesterase 4 Inhibition Offers New Therapeutic Opportunities for Ovarian Ischemia Reperfusion Injury in Rats
4. Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons
5. Ameliorative role of rolipram, PDE-4 inhibitor, against sodium arsenite–induced vascular dementia in rats
6. Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice
7. Rolipram plays an anti-fibrotic effect in ligamentum flavum fibroblasts by inhibiting the activation of ERK1/2
8. Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts
9. Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans
10. Rolipram Attenuates Early Brain Injury Following Experimental Subarachnoid Hemorrhage in Rats: Possibly via Regulating the SIRT1/NF-κB Pathway
11. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents
12. Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25–35 in rats
13. Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats
14. Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex
15. Synthesis of phosphodiesterase IVb inhibitors 2. Stereoselective synthesis of hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one and tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-one derivatives
16. Inhibition of phosphodiesterase-4 decreases ethanol intake in mice
17. Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells
18. Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats
19. Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats
20. Promotion of cAMP Responsive Element-Binding Protein Activity Ameliorates Radiation-Induced Suppression of Hippocampal Neurogenesis in Adult Mice
21. Cyclic AMP-specific PDEs: A promising therapeutic target for CNS repair
22. Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity
23. A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment
24. Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation
25. The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens
26. Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)
27. Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
28. Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors
29. The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
30. Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis
31. Mechanisms of rolipram-induced increase in the incidence of mammary adenocarcinoma: histopathological study of a 104-week oral carcinogenicity study in female Sprague-Dawley rats
32. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats
33. Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium
34. Implications of PDE4 structure on inhibitor selectivity across PDE families
35. Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors
36. Enhancement of the relative uptake of18F-FDG in mouse fibrosarcoma by rolipram
37. Vasoconstriction and vasodilation in erectile physiology
38. Potential of β2-Adrenoceptor Agonists as Add-On Therapy for Multiple Sclerosis: Focus on Salbutamol (Albuterol)
39. Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis
40. Workshops
41. Combined phosphodiesterase inhibition and β-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat
42. Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility
43. Ochratoxin A induced TNFα release from the isolated and blood- free perfused rat liver
44. Purification and physical characterization of cloned human cAMP phosphodiesterases PDE-4D and-4C
45. CDP840: A novel inhibitor of PDE-4
46. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes: Whole-cell cAMP determinations vs broken-cell enzymatic assays
47. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-α generation from human peripheral blood monocytes
48. Hormonal regulation of the contractile vacuole in Amoeba proteus: The role of cyclic nucleotide phosphodiesterases
49. Effect of nitric oxide synthase inhibitor on age-related changes in second messenger systems and calcium channels in rats
50. Effects of chronic treatment with a cyclic AMP-selective phosphodiesterase inhibitor, rolipram, on excitatory amino acid neurotransmission systems in young and aged rat brains
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.